Neos Therapeutics Announces Pricing of Underwritten Public Offering of $25.0 Million of Common Stock
February 03, 2017 08:30 ET
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Feb. 03, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Announces Proposed Offering of Common Stock
February 02, 2017 16:01 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Completes Resubmission of NDA for Cotempla XR-ODT for the Treatment of ADHD
December 20, 2016 07:30 ET
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Dec. 20, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at BMO Prescription for Success Healthcare Conference
December 07, 2016 08:00 ET
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Dec. 07, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release...
Neos Therapeutics Submits NDA for Amphetamine Extended-Release Liquid Suspension Drug Candidate, NT-0201, for the Treatment of ADHD
November 17, 2016 08:00 ET
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Nov. 17, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release...
Neos Therapeutics Reports Third Quarter 2016 Financial Results
November 10, 2016 07:00 ET
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at Stifel 2016 Healthcare Conference
November 08, 2016 08:00 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing and commercializing innovative...
Neos Therapeutics to Host Third Quarter 2016 Financial Results Conference Call on November 10, 2016
November 03, 2016 08:00 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release...
Neos Therapeutics to Present at the Wells Fargo Securities Healthcare Conference on September 8, 2016
August 31, 2016 07:00 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, Aug. 31, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing and commercializing innovative...
Neos Therapeutics Announces Second Quarter 2016 Financial Results
August 11, 2016 07:00 ET
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release...